Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Pudumjee Paper Products Ltd

| Quarterly Financial Results Q3 FY 2025-26

NEUTRAL SENTIMENT

Report Source

⬤31st Jan 26

Summary : Pudumjee Paper Products Ltd. reported standalone unaudited Q3 FY26 results with a slight decline in revenue and profit, and re-appointed Dr. Ashok Kumar as Executive Director for five years, ensuring leadership continuity.

Quarterly Report Analysis & Insights

Financial Disclosures

  1. Cost of materials consumed (Q3 FY26): 10,026 Lakhs.
  2. Employee benefits expenses (Q3 FY26): 1,523 Lakhs.
  3. Fuel, power & water expenses (Q3 FY26): 2,965 Lakhs.
  4. Total Expenses (Q3 FY26): 17,553 Lakhs.
  5. Revenue from operations (Q3 FY26): 20,375 Lakhs.
  6. Other income (Q3 FY26): 450 Lakhs.
  7. Total Income (Q3 FY26): 20,825 Lakhs.
  8. Segment Revenue - Paper (Q3 FY26): 19,419 Lakhs.
  9. Segment Revenue - Hygiene products (Q3 FY26): 1,762 Lakhs.
  10. Total Assets (Q3 FY26): 87,887 Lakhs.
  11. Total Liabilities (Q3 FY26): 22,697 Lakhs.
  12. Paid-up equity capital (Q3 FY26): 950 Lakhs.
  13. Reserves (as per previous year balance sheet): 57,338 Lakhs.
  14. Standalone Unaudited Financial Results.

Corporate Overview

  1. India (Registered Office: Pune, Corporate Office: Mumbai)
  2. Manufacturing and sale of Paper products.
  3. Manufacturing and sale of Hygiene products.
  4. Formal and informative, focusing on compliance and board decisions.
  5. Paper
  6. Hygiene Products

Risk Factors

  1. Quarterly revenue from operations declined.
  2. Profit before tax decreased this quarter.
  3. No specific forward-looking risks disclosed.
  4. Market volatility could impact future performance.

Key Drivers

  1. Dr. Ashok Kumar re-appointed Executive Director.
  2. Company maintains strong regulatory compliance.
  3. Certified Integrated Management System in place.
  4. Continued focus on Paper and Hygiene segments.

Auditor’s Report

  1. Limited Review Report, not an audit opinion.

Board Commentary

  1. Re-appointment of Dr. Ashok Kumar as Executive Director for a period of 5 years (w.e.f. 27th May, 2026 to 26th May, 2031), subject to shareholder approval.
  2. Compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Corporate Governance

  1. Nomination and Remuneration Committee.
  2. Audit Committee.